Company Profiles

driven by the PitchBook Platform

Epiphany Biosciences

Description

Developer of antiviral therapeutics to to prevent the spread of varicella zoster virus (VZV), epstein-barr virus (EBV) and hepatitis C virus (HCV).

2006

Founded

OOB

Status

Out of Business

Latest Deal Type

$36.2M

Total Amount Raised

Description

Developer of antiviral therapeutics to to prevent the spread of varicella zoster virus (VZV), epstein-barr virus (EBV) and hepatitis C virus (HCV).

Website:

www.epiphanybio.com

Ownership Status

Out of Business

Financing Status

Formerly VC-Backed

Primary Industry

Biotechnology

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

One California Street Suite 2800 San Francisco, CA 94111United States +1 (415) 765-7193
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Epiphany Biosciences's full profile, request a free trial.

    Epiphany Biosciences Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Epiphany Biosciences Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Epiphany Biosciences Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Fred Volinsky MDChief Executive Officer, Co-Founder and Chairman
    Michael HoughtonChief Scientific Officer
    Brian MurphyChief Medical Officer
    Steve BlankCo-Founder
    Fred Volinsky MD Chief Executive Officer, Co-Founder and Chairman
    Michael Houghton Chief Scientific Officer
    Brian Murphy Chief Medical Officer
    Steve Blank Co-Founder
    Request full access to PitchBook